CytoReason

@Cytoreason

From data to biology to clinical edge. Machine learning for data-driven target discovery and drug development (indications, combinations & biomarkers)

Israel
Vrijeme pridruživanja: veljača 2018.

Tweetovi

Blokirali ste korisnika/cu @Cytoreason

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Cytoreason

  1. proslijedio/la je Tweet
    Poništi
  2. prije 23 sata

    200 Companies Applying Artificial Intelligence In Drug Discovery and Development | BiopharmaTrend

    Poništi
  3. 4. velj

    A remarkable man delivering remarkable science. Thank you (and for spreading the word)

    Poništi
  4. 4. velj

    From "Companies are eager to speed up the discovery time, so they are working with partners to apply AI in various areas...for example Pfizer has partnered with to improve decision making throughout the drug pipeline"

    Poništi
  5. 2. velj

    Good luck if you want to find a cab in Tel Aviv right now! They are having their own little "Taxit" outside our offices! If, however, you want to uncover key molecular-level for drug discovery & development using , we are still happily beavering away!

    Poništi
  6. 22. sij

    Attending PMWC in Santa Clara? Want to talk about driving novel target discovery and data-driven drug development? 's Tal Sines is there, so DM us here and we'll get you together.

    Poništi
  7. 14. sij

    We love a challenge - talk to us at (or via or contact@cytoreason.com)

    Poništi
  8. 13. sij

    Finding the right combination to develop can be a maze! We can find the right way through – meet us at , email us at contact@cytoreason.com or visit

    Poništi
  9. 12. sij

    Need an indication of the right direction? Our data will provide the clues - meet us at , email us at contact@cytoreason.com or visit

    Poništi
  10. 7. sij

    Disease models that hit the target – meet us at , email us at contact@cytoreason.com or visit

    Poništi
  11. 6. sij

    Challenge us to boost your drug R&D – meet us at , email us at contact@cytoreason.com or visit

    Poništi
  12. 31. pro 2019.

    So unless something huge happens this will be our last tweet of 2019 - and what a fantastic year it has been! Bring it on 2020...

    Poništi
  13. 31. pro 2019.

    Wonderful to be named as one of the top 7 innovations of 2019 (so wonderful we can overlook the unorthodox spelling of our name)! Top 7 AI Innovations From 2019

    Poništi
  14. 22. pro 2019.

    Happy holidays from the team

    Poništi
  15. 18. pro 2019.

    CytoReason recognised by the Government as one of the companies putting "Israel at the center of some of the most important developments in health and medical technology"

    Poništi
  16. 17. pro 2019.

    A quick reference guide to the in players from

    Poništi
  17. 14. pro 2019.
    Poništi
  18. 11. pro 2019.

    Value from AI comes faster from partnering with external AI companies that already have the technology stack, data integration and curation, disease data and expertise: Yilian Yuan from in by

    Poništi
  19. 9. pro 2019.

    A big thanks to the organising team at the International Conference for Innovations in Cardiovascular Interventions. Honoured to have been invited to talk about our aim of improving life for patients across many different diseases, by driving R&D success through machine learning

    Poništi
  20. 8. pro 2019.

    The role of molecular level disease models, built using pharma human clinical data, to improve target discovery and clinical development, explained by CEO, at the today.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·